insights_auto
Why is MOLBIO down 3.12%?
Dive Deeperchevron_right
MOLBIO:NSE
Molbio Diagnostics Limited
₹1,433.00
arrow_downward
-3.12%(-46.20) 1D
Oct 9, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLBIO...
Open
₹1,481.20
High
₹1,488.90
Low
₹1,427.10
Mkt. cap
165.89B
Avg. vol.
3.23M
Volume
779.88K
P/E ratio
96.99
52-wk high
₹1,686.80
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
Open
₹1,481.20
High
₹1,488.90
Low
₹1,427.10
Mkt. cap
165.89B
Avg. vol.
3.23M
Volume
779.88K
P/E ratio
96.99
52-wk high
₹1,686.80
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
News stories
From web sources and news partners
The Manila Times
·
41 minutes ago
Terminal1, the operating system built for public companies, announced today that U.S Gold Corp (NASDAQ:USAU) has joined the Terminal1 platform
Breakingthenews.net
·
12 minutes ago
Dow leads gains on Wall Street, surges 400 points
Investing.com
·
13 minutes ago
Moderna options activity surges as Nasdaq-100 inclusion and melanoma data drive call buying
Nasdaq
·
4 hours ago
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Molbio Diagnostics Limited is an Indian medical diagnostics company headquartered in Verna, Goa, that develops molecular diagnostic technologies. Founded in 2000, the company developed the Truenat platform, a portable real-time PCR system used to diagnose infectious diseases including tuberculosis, HIV, and hepatitis.
The Truenat platform is recognized by the World Health Organization for the initial detection of tuberculosis and rifampicin resistance. Following clinical studies, including research published in The Lancet, the technology has been adopted by national health programs in over 85 countries.
In 2025, Molbio was awarded the Kochon Prize by the Stop TB Partnership, the world's largest award for tuberculosis. Wikipedia
About Molbio Diagnostics Limited